Trial Profile
A Study to Evaluate the Impact of Baseline Hepatitis B Virus (HBV) Load and Antiviral Therapy on Survival of Patients With Advanced HBV Related Hepatocellular Carcinoma (HCC) Treated With Sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 May 2016 New trial record